Nike is set to report earnings after the bell. Here’s what Wall Street expects

Nike is set to report earnings after the bell. Here’s what Wall Street expects


A Nike logo is displayed at a Nike store on Feb. 5, 2026 in Austin, Texas.

Brandon Bell | Getty Images

Nike is expected to report a steep decline in quarterly profit and flat sales on Tuesday as the sneaker giant continues to work through a colossal turnaround under CEO Elliott Hill. 

About a year and a half into his tenure, Hill has made strides in repairing parts of the business, but has been clear that it’ll take time for the entire company to improve given the retailer’s scale and complexity. 

When reporting fiscal second-quarter results in December, Nike said sales rose 9% in North America, its largest market. But the good news was overshadowed by a steep decline in China, where revenue fell 17%. 

What to know about Nike's road ahead in China

Throughout the turnaround, the company has warned that progress would not be linear and some parts of the business would improve faster than others, making it difficult for investors to gauge how long recovery will take. 

Nike’s turnaround attempt was already coming at a tough time as a global trade war dented its efforts to improve profitability and drive sales from inflation-weary shoppers. But now the athletic company will have to contend with a new war in the Middle East that’s already led to rising gas prices and is expected to push consumer prices even higher, which could push shoppers to cut back on nice-to-haves like new clothes and shoes to save money elsewhere. 

On the bright side, Nike will benefit from a range of major sporting events, including the Winter Olympics recently held in the Milan area and the World Cup, happening in North America this summer. 

Given its position in the sports world, Nike is expected to benefit from the events, but perhaps not as much as peers Adidas and Puma, Third Bridge analyst Patrick Ricciardi said in an emailed note. 

Nike is expected to provide its financial guidance during a conference call with analysts at 5 p.m. ET, where investors will be looking out for any updates on its turnaround plan, its current quarter outlook and any color on the fiscal year ahead. 

Here’s what analysts are expecting from the world’s largest sneaker company, according to consensus estimates from LSEG:

  • Earnings per share: 28 cents
  • Revenue: $11.24 billion 

Another key area of focus for investors will be progress in North America during the the company’s holiday quarter, its busiest season of the year. Last quarter, Nike saw gains in the region, but some investors wondered whether consumers had pulled forward purchases due to tariffs and whether outsized gains in wholesale revenue were sustainable as the retailer repairs relationships with key partners. 

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source

Tom Brady, famed health nut, explains his junk food endorsements in retirement: ‘Moderation in all things’
Business

Tom Brady, famed health nut, explains his junk food endorsements in retirement: ‘Moderation in all things’

From Pizza Hut to Dunkin’, Tom Brady is seemingly everywhere these days promoting food brands he once wouldn’t have touched during his NFL playing days. The seven-time Super Bowl winning quarterback famously followed a strict health-focused diet and once referred to soda and sugary cereals as “poison for kids.” But Brady says he’s softened his […]

Read More
Mercedes U.S. CEO sets ambitious sales goal despite ‘tougher’ market than anticipated
Business

Mercedes U.S. CEO sets ambitious sales goal despite ‘tougher’ market than anticipated

Mercedes-Benz USA CEO Adam Chamberlain said Tuesday that 2026 is shaping up to be more challenging than expected.   “If you look at the market in the first couple of months of the year, the market environment is definitely a little tougher than we anticipated,” Chamberlain told CNBC at the company’s manufacturing plant in Vance, […]

Read More
Lilly to spend up to .8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Business

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said Tuesday. Centessa is one of several companies working […]

Read More